Weidi Sun1,2, Hui Zhang2,3, Wanlin Xie2

  • 1Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Province, Hunan University, Changsha, Hunan 410082, China.

概括

lysosome-targeting chimeras (LYTACs) 提供了一种降解膜蛋白的新方法. 研究人员开发了因整蛋白α3β1 (ITGA3B1) 促成的双特异性体仿真体 (ITGBACs),用于改善蛋白质降解和癌症治疗.